Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preclinical
Biotech
Moderna CEO: Mpox vaccine development is not a high priority
Moderna CEO said that developing an mpox vaccine is not high on the company's priority list, citing the current state of the disease outbreak.
Max Bayer
Jan 4, 2023 9:49am
Blueprint drops $250M on Lengo for preclinical lung cancer med
Nov 29, 2021 10:20am
Roche's Spark adds epilepsy asset to pipeline with $328M deal
Oct 12, 2021 10:25am
Abata launches with $95M series A for MS cell therapy
Jun 23, 2021 7:00am
TRexBio roars with dino-mite snags of CEO, CMO, Big Pharma cash
Jun 22, 2021 10:50am
CAMP4 reimagines itself with $45M for regulatory RNAs
Jun 15, 2021 6:30am